CPLENISH Trademark Information

Trademark by Lev Pharmaceuticals, Inc.

pharmaceutical preparations for the treatment of conditions associated with inflammatory processes, namely, hereditary angioedema, myocardial infarction, rheumatoid arthritis, inflammatory bowel disease, gram-negative septicemia, ischemic-reperfusion injury, Alzheimer's disease and strokes

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: CPLENISH
Status/Status Date:
ABANDONED - NO STATEMENT OF USE FILED
10/5/2009
Serial Number: 77212447
Filing Date: 6/21/2007
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: pharmaceutical preparations for the treatment of conditions associated with inflammatory processes, namely, hereditary angioedema, myocardial infarction, rheumatoid arthritis, inflammatory bowel disease, gram-negative septicemia, ischemic-reperfusion injury, Alzheimer's disease and strokes
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 6/10/2008
Last Applicant/Owner:
Lev Pharmaceuticals, Inc.
New York 10017
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Morgan, Lewis & Bockius LLP
TMSU
1111 Pennsylvania Ave., N.W.
Washington DC 20004
Current Status:
ABANDONED - NO STATEMENT OF USE FILED
10/5/2009
Correspondent Search:
Anita B. Polott is a correspondent of CPLENISH trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on